US20100028489A1 - Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization - Google Patents

Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization Download PDF

Info

Publication number
US20100028489A1
US20100028489A1 US12/444,429 US44442907A US2010028489A1 US 20100028489 A1 US20100028489 A1 US 20100028489A1 US 44442907 A US44442907 A US 44442907A US 2010028489 A1 US2010028489 A1 US 2010028489A1
Authority
US
United States
Prior art keywords
fermented
matrix
symbiotic matrix
cereals
fermented symbiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/444,429
Other languages
English (en)
Inventor
Francisco Xavier Delgado Domingos Antunes Malcata
Ana Maria Pereira Gomes
Joana Mafalda Patricio Oliveira Fernandes Inacio
Maria Isabel Moreira Da Costa Franco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ESCOLA SUPERIOR DE BIOTECNOLOGIA
Original Assignee
ESCOLA SUPERIOR DE BIOTECNOLOGIA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ESCOLA SUPERIOR DE BIOTECNOLOGIA filed Critical ESCOLA SUPERIOR DE BIOTECNOLOGIA
Assigned to ESCOLA SUPERIOR DE BIOTECNOLOGIA reassignment ESCOLA SUPERIOR DE BIOTECNOLOGIA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DELGADO DOMINGOS ANTUNES MALCATA, FRANCISCO XAVIER, PEREIRA GOMES, ANA MARIA
Publication of US20100028489A1 publication Critical patent/US20100028489A1/en
Priority to US14/547,789 priority Critical patent/US20150071891A1/en
Priority to US16/421,266 priority patent/US11707494B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/115—Cereal fibre products, e.g. bran, husk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Definitions

  • the present invention is related with the manufacture of a pre-fermented symbiotic matrix, containing prebiotics and/or probiotics, and it is applicable to the pharmaceutical, cosmetic and preferably food industries, including pet food.
  • the pre-fermented symbiotic matrix, free or not of dairy ingredients, applies to all populations, in particular to those elements with intolerance and/or allergy to dairy products.
  • the present invention's object is the development of a cereal symbiotic matrix, oat preferably, pre-fermented with encapsulated probiotics and free and/or encapsulated prebiotics, with the purpose of complementing the actual functional food market and solving problems inherent to the reduced shelf-life period of these foods. Moreover, the present invention's object is to improve the fermentative process conditions at different levels, namely reduction of fermentation time as a means to economize energy during the manufacturing process, to reduce the risk of contamination and to maintain long term microbial stability.
  • This market is characterized by being dynamic and innovative with a market quota of 10 to 15% and a growth rate of 20 to 30% per year, at world level.
  • Probiotics can be defined as viable microorganisms that affect the host beneficially in as much as they promote the balance of its intestinal bacterial ecosystem. Lactobacillus, Bifidobacterium and Enterococcus , genera considered potentially probiotic, offer a protection to the host against infections, considering that they prevent the attack, setting, response and/or virulence of specific enteropathogenics (antimicrobial activity). These probiotics also have a beneficial effect in the control of diarrhoeas, as well as in the reduction of the risk of development of some forms of cancer (anticarcinogenic activity). An effect on reduction levels of blood cholesterol (hypocholesterolaemic activity) is also described.
  • Another possible effect is the effect on the digestion of lactose, through the production of lactase ( ⁇ -galactosidase) which facilitates the digestion of this sugar, and offers solutions for individuals intolerant to lactose.
  • lactase ⁇ -galactosidase
  • the probiotic products' beneficial effect is secured when these contain a minimum of 10 6 CFU/ml, which is in agreement with the assumption of a minimum therapeutic dose per day suggested to be 10 8 to 10 9 viable cells, which may be realisable through an intake of approximately 100 grams of product containing 10 6 -10 7 viable cells per millilitre or gram.
  • Probiotics present natural limitations to their health benefits, due to their susceptibility to certain technological and functional factors, for instance high levels of oxygen, acid environments, freezing and the passage through the gastrointestinal tract.
  • Microencapsulation is the technology of packing solids, liquids or gases in very small capsules, capable of releasing their content at controlled rates and under specific conditions.
  • Emulsion encapsulation consists on adding a small volume of solution containing microbial cells and polymers (discontinuous phase) to a greater volume of vegetable oil (continuous phase). This mixture is then homogenized forming a water-in-oil emulsion. Once obtained, the water soluble polymer must be insolubilized via a saline solution with the objective of creating small gel particles in the oil phase.
  • the size of the capsules can be controlled by varying the type of stirring and its speed as well as the saline solution addition mechanism. The process of emulsion encapsulation is easily scaled-up and leads great survival rates of microorganisms (80 to 95%). The resulting capsules present various sizes, which range from 25 ⁇ m to 50 ⁇ m.
  • the spray-drying method consists on drying an aqueous encapsulating agent mixture with viable microbial cells, using an atomizer.
  • the drying occurs when the solution, after being vaporized, comes in contact with a hot air flow (entry temperature), and is subsequently, with the aid of a vacuum, gathered in the appropriate recipient.
  • This technology has as greatest advantages the low cost of the procedure, the easiness of the operation, the possibility of using thermo-sensitive functional ingredients, the high quality/stability of the capsules obtained and the easy production in large quantities.
  • the obtained capsules can vary in size between 5 and 75 ⁇ m.
  • a prebiotic is by definition a non-digestible food ingredient which positively affects the host, stimulating selectively the growth and/or activity of one or a limited number of bacteria in the colon.
  • symbiotic refers to a synergistic association of pre- and probiotic agents with physiological activity in the same food.
  • prebiotics and their combination with probiotics in an encapsulated form consist in an investment for food industry, with the intention of maintaining their long term stability and optimizing the nutritional qualities of the associated product.
  • the document US2001/0016220 lists components of food products, which contain biological active ingredients that may be encapsulated, as well as the process for their production and utilization.
  • the components mentioned in this document comprise plant fibres including the ones proceeding from oats, soluble and insoluble polysaccharides, pectins, lenhins and gums.
  • the biologically active components in the mentioned plant fibres may be probiotic microorganisms, prebiotics, enzymes, nutrients, secondary metabolites, natural or synthetic, substances with antioxidant activity, etc.
  • the substances of encapsulation may be constituted by polysaccharides (of plant or microbial origin), emulsifiers, peptides, proteins and prebiotic substances.
  • the document WO2005.002367 reports products and therapeutical compositions made of oats free of probiotic microorganisms, including proteins, hydrolysed proteins and emulsifying lipids. Besides that, the products and compositions may still include ⁇ -glucans, and plant sterols. The corresponding production process is carried out via an enzymatic treatment of the oats fraction for removal of the carbohydrates (preferentially by hydrolysis).
  • the document Wo02.065855 mentions non dairy products, made of cereal dispersions, containing ⁇ -glucans, proteins, natural sugars and proteins.
  • the process to obtain such products uses enzymes, particularly hydrolases, as well as isomerases, applied to cereal suspensions.
  • the document WO02/37984 reports products leavened by microbial cultures based on oat suspensions, free of soy and milk, as well as the corresponding manufacture.
  • This document foresees the use of Lactobacillus and Streptococcus strains in the fermentation of the oat suspension, as well as the inclusion of several components, such as calcium hydrogeno-phosphate and/or calcium phosphate, ⁇ -glucan, maltose, maltodextrin, proteins, etc in an aqueous oat suspension which is later incubated for fermentation.
  • the document WO00/65930 reports products made of cereals, particularly oats, for further utilization as raw material in the food industry.
  • the process of attainment of these products includes the preparation of a suspension, from bran, flakes or flour of cereals. This suspension is later homogenized, at a predetermined temperature and pressure, in order to obtain an emulsion. Afterwards, the emulsion can be leavened by microorganisms, such as Lactobacillus and Bifidobacterium , among others, acidified and finally pasteurized, (or even presented as a powder).
  • microorganisms such as Lactobacillus and Bifidobacterium , among others, acidified and finally pasteurized, (or even presented as a powder).
  • the document CA2383021 describes symbiotic compositions departing from ⁇ -glucans produced from cereals, obtained from flours or extracts of cereals, inoculated by bacteria for fermentation. Lactobacillus, Streptococcus and/or Bifidobacterium are inoculated in aqueous suspensions of cereals, treated with ⁇ -amylases, and added with a stabilizing agent.
  • WO2004/037191 describes symbiotic products, in liquid or frozen form, derived from soy or dairy products, composed of a mixture of probiotic components (e.g. Lactobacillus and Bifidobacterium ) and prebiotics, in which these may be constituted by polymers, particularly, inulin or oligofructose.
  • probiotic components e.g. Lactobacillus and Bifidobacterium
  • prebiotics in which these may be constituted by polymers, particularly, inulin or oligofructose.
  • the process of manufacture thereof uses a mixture of prebiotic and probiotic components in a liquid phase; fermentation of this mixture occurs until pH reaches 4.5; and final blend leads to the final product. At this final stage, it is, still possible to include a percentage of carbon dioxide.
  • the content described in the six aforementioned documents differs substantially from the content of our invention, since they describe the fermentation of oat suspensions, with the addition of free microorganisms or enzymes, in just one phase, and may eventually include other additional components, while the invention under analysis describes suspensions of cereals pre-fermented by immobilized microorganisms, to which encapsulated probiotics and free or encapsulated prebiotics are subsequently added.
  • the shelf-life of the final product is reduced and the stability/viability of microorganisms over the storage period as well as in their passage through the gastro-intestinal tract is diminished, in comparison to the symbiotic pre-fermented matrix with encapsulated probiotics (increase of 40 to 60%), object of the present invention.
  • the document EP 0 862 863 A2 has for object of invention the development of dried extruded cereals with surface and/or enclosed microorganisms, and with soluble fibre sources listing as examples of application breakfast cereals and animal feed.
  • the object of invention foresees the development of a cereal symbiotic matrix, preferentially in oatmeal, pre-fermented with encapsulated probiotics and free and/or encapsulated prebiotics, which, when applied together, will confer a stabilizing effect on the microorganisms present in the final product and favour the passage through the gastrointestinal tract.
  • an additional object of this invention is the health claim of cholesterol reduction associated to p-glucan, as a source of non-digestible prebiotic soluble fibres.
  • the cereal suspension, preferentially oatmeal is presented in fresh, lyophilized, and frozen forms, adapted to the needs of the intervening parts in the food chain, and hence with several applications in the food industry.
  • the document WO2004.070026 discloses continuous processes concerning yeast immobilization in ⁇ -carrageenan or alginate gel spheres, e.g. in beer production, through formation of an emulsion e.g. with the continuous non-aqueous phase (plant oil) and the disperse aqueous phase (inoculated ⁇ -carrageenan with yeast), using static stirrers.
  • This subject differs from that disclosed in the present invention, because the immobilization process described, although pertaining to an emulsion between a plant oil and a microorganism-inoculated polymer, encompasses a yeast, whereas those in the present invention are all of probiotic microorganisms.
  • the present invention reports a cereal symbiotic matrix, preferentially oatmeal, pre-fermented with encapsulated probiotic and prebiotic compounds, its process of manufacture and its use in several applications, especially in the food industry but also in the pharmaceutical industry or similar counterparts.
  • the products obtained possess organoleptic characteristics that are identical to those produced by traditional fermentation processes.
  • these products When encapsulated microorganisms are included, these products also have the advantage of increasing their viability/stability, either as a long shelf-life or during passage through the gastro-intestinal tract following ingestion.
  • the matrices also present, as an additional advantage, an extended expiration date up to 40% to 60% higher than those presented by available products on the market.
  • the immobilization technique of microbial cells confers advantages in comparison to free cell systems, such as: (i) reduction in fermentation time up to 50 to 60%; (ii) increase of the microbial metabolism and stability; (iii) reduced risk of contamination; (iv) higher cell density; (v) stable product quality associated with a decrease of post-acidification risk due to probiotic action, for example; (vi) improved substrate use and (vii) long time cell reutilization due to constant cellular regeneration.
  • the process of obtaining these products reveals a method for improvement of the fermentative process conditions at several levels such as, (i) continuous reutilization of the immobilized cells; (ii) fermentation time reduction contributes to energy saving throughout the process, (iii) reduction of contaminating risks and (iv) long term maintenance of microbial stability.
  • the process of pre-fermentation is performed in a fluidized bed reactor with immobilized microorganisms by cells obtained in steps 2.1.1. through 2.4.3.
  • the capsules are introduced in a column, with porosity smaller than the diameter of the capsules to induce the microorganisms-matrix interaction, inside the pressurized reactor with constant and controlled bi-directional nitrogen flow.
  • the immobilized cells inside the column are reutilized in the fermentation process until they lose their metabolic properties.
  • the process of pre-fermentation is performed at a temperature between 20° C. to 52° C., during 4 to 8 hours, under sterile and anaerobic conditions (circulating nitrogen flux), resulting in a fermented matrix. This suspension is drained into the reactor where the incorporation of the remaining food ingredients occurs.
  • microorganisms' encapsulation is done using the encapsulation techniques:
  • the pre-fermented symbiotic matrix based on an oat suspension with encapsulated probiotics can be presented either in a fresh form, lyophilized and/or frozen.
  • the fresh matrix can be further presented either in gel or extruded form.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
US12/444,429 2006-10-06 2007-10-04 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization Abandoned US20100028489A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/547,789 US20150071891A1 (en) 2006-10-06 2014-11-19 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization
US16/421,266 US11707494B2 (en) 2006-10-06 2019-05-23 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT103582A PT103582B (pt) 2006-10-06 2006-10-06 Matriz simbiótica pré-fermentada com base numa suspensão de aveia e probióticos encapsulados, processo de obtenção e respectiva utilização
PT103582 2006-10-06
PCT/PT2007/000042 WO2008041876A2 (en) 2006-10-06 2007-10-04 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding uti lization

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/PT2007/000042 A-371-Of-International WO2008041876A2 (en) 2006-10-06 2007-10-04 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding uti lization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/547,789 Continuation US20150071891A1 (en) 2006-10-06 2014-11-19 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization

Publications (1)

Publication Number Publication Date
US20100028489A1 true US20100028489A1 (en) 2010-02-04

Family

ID=39185902

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/444,429 Abandoned US20100028489A1 (en) 2006-10-06 2007-10-04 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization
US14/547,789 Abandoned US20150071891A1 (en) 2006-10-06 2014-11-19 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization
US16/421,266 Active 2029-05-18 US11707494B2 (en) 2006-10-06 2019-05-23 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/547,789 Abandoned US20150071891A1 (en) 2006-10-06 2014-11-19 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization
US16/421,266 Active 2029-05-18 US11707494B2 (en) 2006-10-06 2019-05-23 Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization

Country Status (21)

Country Link
US (3) US20100028489A1 (zh)
EP (1) EP2068648B1 (zh)
JP (1) JP5490538B2 (zh)
KR (1) KR20090077781A (zh)
CN (1) CN101534658B (zh)
AU (1) AU2007302899B2 (zh)
BR (1) BRPI0718080B1 (zh)
CA (1) CA2665558C (zh)
CY (1) CY1120416T1 (zh)
DK (1) DK2068648T3 (zh)
ES (1) ES2675916T3 (zh)
HU (1) HUE039469T2 (zh)
LT (1) LT2068648T (zh)
MX (1) MX2009003677A (zh)
PL (1) PL2068648T3 (zh)
PT (2) PT103582B (zh)
RU (1) RU2440010C2 (zh)
SI (1) SI2068648T1 (zh)
TR (1) TR201809682T4 (zh)
WO (1) WO2008041876A2 (zh)
ZA (1) ZA200903139B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017003263A1 (ko) * 2015-07-01 2017-01-05 (주) 위드바이오코스팜 신바이오틱 발효 산물의 제조 방법 및 이에 의하여 제조된 신바이오틱 발효산물

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT103582B (pt) * 2006-10-06 2008-08-22 Joana Mafalda Patricio Inacio Matriz simbiótica pré-fermentada com base numa suspensão de aveia e probióticos encapsulados, processo de obtenção e respectiva utilização
ES2368401B2 (es) 2011-09-30 2013-06-27 Universidad Miguel Hernández De Elche Productos gelificados probióticos o simbióticos y procedimiento para su obtención.
CN103013970A (zh) * 2012-11-29 2013-04-03 上海致一食品有限公司 同时富含植物纤维与益生菌的固定化益生菌及其制备方法
CN104721652A (zh) * 2015-02-11 2015-06-24 江苏大学 乳酸菌发酵大麦粉及其制备方法与用途
GR1010362B (el) * 2021-07-06 2022-12-21 Πανας Π. - Κλαουδατος Α. Οε, Διεργασια ακινητοποιησης προβιοτικων κυτταρων σε βρωμη για παραγωγη προϊοντων-σνακ εμπλουτισμενων με προβιοτικα

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879729A (en) * 1994-01-13 1999-03-09 Nestec S.A. Composition and process useful for reducing the fat caloric content of foodstuffs containing fats and oils
US6060050A (en) * 1994-09-16 2000-05-09 The University Of New South Wales Probiotic compositions
US20010016220A1 (en) * 1999-12-22 2001-08-23 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Encapsulated multifunctional biologically active food component, process for its production and its use
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US20030170370A1 (en) * 2000-06-19 2003-09-11 Evenson Keith A. Nutrient clusters for food products and methods of preparation
US6652895B2 (en) * 1993-04-16 2003-11-25 Mccormick & Company, Inc. Encapsulation compositions
US6783780B1 (en) * 1998-12-09 2004-08-31 N.V. Nutricia Preparation that contains oligosaccharides and probiotics
US20040175460A1 (en) * 2001-07-23 2004-09-09 Zenovich Sergei Mikhailovich Method for producing a food product, food product and barm for producing said product (variants)
US20050079244A1 (en) * 2001-11-12 2005-04-14 Giffard Catriona Julie Foodstuff
US20050153018A1 (en) * 2002-03-12 2005-07-14 Nestec S.A. Probiotic delivery system
US20060099321A1 (en) * 2002-08-07 2006-05-11 Nestec S.A. Cereal based food product comprising dha and/or epa

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE463796B (sv) * 1988-03-09 1991-01-28 Carl Erik Albertsson Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition
US5554520A (en) * 1988-08-31 1996-09-10 Bioenergy International, L.C. Ethanol production by recombinant hosts
JP2890746B2 (ja) * 1989-08-24 1999-05-17 日本油脂株式会社 高安定性腸内有用細菌を含有する食品
FI88856C (fi) * 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
AU687253C (en) * 1994-09-16 2003-07-17 Corn Products Development, Inc. Probiotic compositions
PT862863E (pt) 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
CA2281463A1 (en) * 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
US6555003B2 (en) * 2001-01-19 2003-04-29 Basic American, Inc. Potato wastewater treatment method
RU2302747C2 (ru) * 2001-02-19 2007-07-20 Сосьете Де Продюи Нестле С.А. Продукт питания из злаков, содержащий пробиотический микроорганизм, продукт питания из злаков, содержащий метаболиты, продуцированные пробиотическими микроорганизмами, и способы их получения
EE200100181A (et) * 2001-03-23 2002-12-16 L�unat��stuse AS Meetod biolaguneva piimhappepolümeeri saamiseks ja selliselt saadud piimhappepolümeeri kasutamine
CA2383021C (en) * 2001-04-23 2009-04-07 Ceapro Inc. Cereal .beta. glucan - probiotic compositions
US7182943B2 (en) * 2002-05-15 2007-02-27 UNIVERSITé LAVAL Method and system for modulation of microbial cell characteristics
WO2004037191A2 (en) * 2002-10-22 2004-05-06 University Of Vermont And State Agriculture College Symbiotic food products comprising oats and methods for manufacturing the same
FI20031004A0 (fi) * 2003-07-03 2003-07-03 Raisio Benecol Oy Uusi syötävä koostumus
CN1207384C (zh) * 2003-08-14 2005-06-22 南京农业大学 乳酸菌细胞微包囊培养方法及其生产的发酵剂
US8304217B2 (en) * 2003-11-26 2012-11-06 Premier Research Labs, Lp Stabilized dihydrolipoic acid and method of producing same
MX2007000089A (es) * 2004-07-01 2007-06-14 Gen Mills Inc Cultivos encapsulados con cereales de desayuno de grasa compuesta recubiertos con grasa compuesta y metodos de preparacion.
JP3706628B1 (ja) * 2004-07-07 2005-10-12 株式会社東洋新薬 麦若葉加工物を含有する造粒物
PT103582B (pt) * 2006-10-06 2008-08-22 Joana Mafalda Patricio Inacio Matriz simbiótica pré-fermentada com base numa suspensão de aveia e probióticos encapsulados, processo de obtenção e respectiva utilização
US20090311376A1 (en) * 2008-06-11 2009-12-17 21St Century Grain Processing Method of producing modified whole grain oat flour and products containing modified whole grain oat flour
AU2014332536A1 (en) * 2013-10-11 2016-05-05 Uppala RAJAKARUNA Food additives and methods of making and using same
WO2016173929A1 (en) * 2015-04-29 2016-11-03 Nestec S.A. Sugar reduction of food products
US20190246676A1 (en) * 2016-10-06 2019-08-15 Manildra Milling Corporation Gluten-free resistant starch and method of making the same

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6652895B2 (en) * 1993-04-16 2003-11-25 Mccormick & Company, Inc. Encapsulation compositions
US5879729A (en) * 1994-01-13 1999-03-09 Nestec S.A. Composition and process useful for reducing the fat caloric content of foodstuffs containing fats and oils
US6060050A (en) * 1994-09-16 2000-05-09 The University Of New South Wales Probiotic compositions
US6783780B1 (en) * 1998-12-09 2004-08-31 N.V. Nutricia Preparation that contains oligosaccharides and probiotics
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US20010016220A1 (en) * 1999-12-22 2001-08-23 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Encapsulated multifunctional biologically active food component, process for its production and its use
US20030170370A1 (en) * 2000-06-19 2003-09-11 Evenson Keith A. Nutrient clusters for food products and methods of preparation
US20040175460A1 (en) * 2001-07-23 2004-09-09 Zenovich Sergei Mikhailovich Method for producing a food product, food product and barm for producing said product (variants)
US20050079244A1 (en) * 2001-11-12 2005-04-14 Giffard Catriona Julie Foodstuff
US20050153018A1 (en) * 2002-03-12 2005-07-14 Nestec S.A. Probiotic delivery system
US20060099321A1 (en) * 2002-08-07 2006-05-11 Nestec S.A. Cereal based food product comprising dha and/or epa

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017003263A1 (ko) * 2015-07-01 2017-01-05 (주) 위드바이오코스팜 신바이오틱 발효 산물의 제조 방법 및 이에 의하여 제조된 신바이오틱 발효산물

Also Published As

Publication number Publication date
PT103582A (pt) 2008-04-30
PL2068648T3 (pl) 2018-12-31
BRPI0718080B1 (pt) 2018-07-10
EP2068648B1 (en) 2018-04-11
PT103582B (pt) 2008-08-22
WO2008041876A2 (en) 2008-04-10
JP5490538B2 (ja) 2014-05-14
AU2007302899B2 (en) 2013-05-02
ZA200903139B (en) 2010-08-25
WO2008041876A4 (en) 2008-12-31
PT2068648T (pt) 2018-07-11
SI2068648T1 (sl) 2018-09-28
US20190307814A1 (en) 2019-10-10
CA2665558A1 (en) 2008-04-10
RU2009114987A (ru) 2010-11-20
JP2010505823A (ja) 2010-02-25
LT2068648T (lt) 2018-07-25
US11707494B2 (en) 2023-07-25
WO2008041876A3 (en) 2008-11-06
CY1120416T1 (el) 2019-07-10
CA2665558C (en) 2017-11-21
EP2068648A2 (en) 2009-06-17
BRPI0718080A2 (pt) 2014-10-29
HUE039469T2 (hu) 2019-01-28
TR201809682T4 (tr) 2018-07-23
DK2068648T3 (en) 2018-07-02
ES2675916T3 (es) 2018-07-13
AU2007302899A1 (en) 2008-04-10
RU2440010C2 (ru) 2012-01-20
KR20090077781A (ko) 2009-07-15
US20150071891A1 (en) 2015-03-12
MX2009003677A (es) 2009-09-18
CN101534658B (zh) 2014-03-12
CN101534658A (zh) 2009-09-16

Similar Documents

Publication Publication Date Title
US11707494B2 (en) Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization
Enujiugha et al. Probiotic potentials of cereal-based beverages
Figueroa‐González et al. Probiotics and prebiotics—perspectives and challenges
Beheshtipour et al. Supplementation of Spirulina platensis and Chlorella vulgaris algae into probiotic fermented milks
US10576113B2 (en) Method of preparing stable, water soluble probiotic compositions based on millets and similar cereals
CN108991327A (zh) 一种益生菌固体饮料及其制备方法
US20010016220A1 (en) Encapsulated multifunctional biologically active food component, process for its production and its use
Nakkarach et al. Comparison of synbiotic beverages produced from riceberry malt extract using selected free and encapsulated probiotic lactic acid bacteria
Lai et al. Microencapsulation of Lactobacillus plantarum 299v and its storage in kuini juice.
Ahire et al. Developing formulations of prebiotics and probiotics
Khosroshahi et al. Mixed fermentation and electrospray drying for the development of a novel stabilized wheat germ powder containing highly viable probiotic cultures
Cavender et al. Improving the survival of Lactobacillus plantarum NRRL B-1927 during microencapsulation with ultra-high-pressure-homogenized soymilk as a wall material
EP4012017A1 (en) Method for preparing pure plant-based microbial culture
Kouamé et al. Development and characterization of probiotic (co) encapsulates in biopolymeric matrices and evaluation of survival in a millet yogurt formulation
JP2006280263A (ja) ビフィズス菌菌体粉末
CN107660670A (zh) 苦荞益生菌饮品及其制备方法
C Perotti et al. Dairy products modified in their lactose content
Othman et al. Study on the effects of carbohydrate-protein-coconut oil on the viability of Lactobacillus bulgaricus during spray drying, simulated gastrointestinal conditions and unrefrigerated storage by simplex-lattice mixture design
Salovaara et al. Fermented cereal-based functional foods
CN107897932A (zh) 一种合生素制剂
CN109953335A (zh) 麦绿素的新用途及其与益生菌的营养组合物
Polanía et al. Advancement in the Research and Development of Synbiotic Products
Starovoitova Synbiotics based on plant raw materials
KR20220114720A (ko) 기능성 요거트 및 이의 제조방법
Krunića et al. Scientific paper

Legal Events

Date Code Title Description
AS Assignment

Owner name: ESCOLA SUPERIOR DE BIOTECNOLOGIA,PORTUGAL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DELGADO DOMINGOS ANTUNES MALCATA, FRANCISCO XAVIER;PEREIRA GOMES, ANA MARIA;REEL/FRAME:023313/0369

Effective date: 20090402

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION